Skip to main content
letter
. 2021 May 29;34(4):975–983. doi: 10.1007/s40620-021-01076-0

Fig. 2.

Fig. 2

SARS-CoV-2 IgG (A) and IgM (B) spike levels in HD and PD patients and staff 2 weeks after first vaccination and in HD patients after COVID-19 infection. A Median (1;3 quartile). HD patients 2 weeks after first vaccination (N = 23): 1.6 (0–14.5) AU/mL. PD patients 2 weeks after first vaccination (N = 4): 180.7 (82.5–241.9) AU/mL. Staff 2 weeks after first vaccination (N = 14): 73.1 (16.1–1324.5) AU/mL. HD patients after COVID-19 (N = 18): 818.4 (1.6–7806.1) AU/mL. B Median (1;3 quartile). HD patients 2 weeks after first vaccination (N = 23): 0.04 (0.03–0.21) Index. PD patients 2 weeks after first vaccination (N = 4): 0.08 (0.07–0.32) Index. Staff 2 weeks after first vaccination (N = 14): 0.34 (0.22–1.67) Index. HD patients after COVID-19 (N = 18): 0.86 (0.03–7.46) Index. Missing values IgG and IgM spike: N = 0. HD, hemodialysis. PD, peritoneal dialysis